Compumedics Ltd (ASX: CMP) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Compumedics Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $57.93 million
P/E Ratio 1,100.00
Dividend Yield 0.00%
Shares Outstanding 199.76 million
Earnings per share 0.000
Dividend per share N/A
Year To Date Return -13.43%
Earnings Yield 0.09%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Compumedics Ltd (ASX: CMP)
Latest News

a woman
⏸️ Investing

Why these 4 ASX shares started the week in the red

The Japara Healthcare Ltd (ASX:JHC) share price is one of four starting the week in the red. Here’s why…

Read more »

a woman
⏸️ Investing

Why the Compumedics Limited share price fell 19% today

The Compumedics Limited (ASX:CMP) share price has dropped sharply today following the release of a business update. Is this a…

Read more »

a woman
⏸️ Investing

Why these 4 ASX shares are ending the week deep in the red

The Coca-Cola Amatil Ltd (ASX:CCL) share price is one of four ending the week deep in the red. Here’s why…

Read more »

a woman
⏸️ Investing

Why these 4 ASX shares have jumped higher today

The Bubs Australia Ltd (ASX:BUB) share price is one of four posting strong gains today. Here’s what you need to…

Read more »

a woman
⏸️ Investing

Why the Compumedics Limited share price rocketed 43% higher

The Compumedics Limited (ASX:CMP) share price has had a great day. Here’s why its shares are up 43% today…

Read more »

a woman
⏸️ Investing

3 ASX shares at 52-week lows: Are they in the bargain bin?

The Mayne Pharma Group Ltd (ASX:MYX) share price is one of three that fell to a 52-week last week. Does…

Read more »

a woman
⏸️ Investing

Top stock picks for February

BWX Ltd (ASX:BWX), Technology One Limited (ASX:TNE) and TPG Telecom Ltd (ASX:TPM) are among February's top picks.

Read more »

a woman
⏸️ Investing

4 small-cap healthcare shares that you need to know about

The ASX has a number of exciting small-cap healthcare shares on the rise.

Read more »

a woman
⏸️ Investing

3 small-cap shares on my radar for 2017

These three small-cap shares offer unique investment opportunities.

Read more »

a woman
⏸️ Investing

4 shares under $1 with huge potential

These four shares are already profitable and have exciting long-term growth prospects.

Read more »

a woman
⏸️ Investing

5 small caps that could be the blue-chips of tomorrow

Here are five hot growth shares to watch.

Read more »

CMP ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Compumedics Ltd

Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.

CMP Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
20 Mar 2026 $0.29 $0.01 3.51% 92,865 $0.28 $0.29 $0.28
19 Mar 2026 $0.29 $-0.01 -3.45% 159,819 $0.28 $0.29 $0.28
18 Mar 2026 $0.29 $-0.02 -6.56% 69,641 $0.28 $0.29 $0.28
13 Mar 2026 $0.31 $-0.02 -6.25% 185,430 $0.29 $0.31 $0.29
12 Mar 2026 $0.32 $0.02 6.67% 20,000 $0.31 $0.32 $0.31
11 Mar 2026 $0.30 $0.02 7.14% 31,000 $0.30 $0.30 $0.30
10 Mar 2026 $0.28 $-0.02 -6.67% 125,092 $0.29 $0.29 $0.28
09 Mar 2026 $0.30 $-0.01 -3.28% 97,058 $0.29 $0.31 $0.29
06 Mar 2026 $0.31 $0.01 3.33% 220,188 $0.30 $0.31 $0.30
05 Mar 2026 $0.30 $-0.01 -3.28% 98,634 $0.30 $0.30 $0.30
04 Mar 2026 $0.31 $-0.01 -3.17% 31,021 $0.31 $0.31 $0.31
03 Mar 2026 $0.32 $-0.02 -6.06% 17,602 $0.32 $0.32 $0.32
27 Feb 2026 $0.33 $0.01 3.13% 20,750 $0.32 $0.33 $0.31
26 Feb 2026 $0.32 $-0.01 -3.01% 63,178 $0.33 $0.33 $0.32
25 Feb 2026 $0.33 $-0.01 -2.94% 40,243 $0.35 $0.35 $0.33
24 Feb 2026 $0.34 $-0.01 -2.86% 36,309 $0.33 $0.34 $0.33
20 Feb 2026 $0.35 $0.01 2.90% 8,197 $0.35 $0.35 $0.35

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr David Burton Chief Executive OfficerExecutive ChairmanExecutive Director Nov 1987
Dr Burton is the founder and major shareholder through a related entity. His background includes the design and project management of Compumedics' first sleep laboratory and portable sleep systems. He has authored fifteen patents or patent applications that form part of Compumedics' key intellectual property. He has experience in the development, design, manufacture and sale of medical devices and in business development. He is also Chairman of the Board.
Mr David Lawson Chief Financial OfficerCompany SecretaryExecutive Director Oct 2013
Mr Smith has experience in the development of the Compumedics business over the last 26 years and previously held several management positions with another listed public entity.
Mr Rod James North Non-Executive Director Oct 2022
Mr North has over 30 years of experience in the financial and corporate sectors, having worked in share broking, investment and funds management, and in investor relations, media, and public relations for a range of ASX-listed companies over the past 19 years. He has experience in company analysis and financial management and has served on several investment committees in funds management. He has also acted in advisory roles to private and public companies at senior executive and board levels, focusing on capital raisings, communication, and investor relations strategies.
Mr Christopher R Barys Non-Executive Director Sep 2025
Mr Barys is a U.S. MedTech executive with over 30 years of leadership at companies including Johnson & Johnson, Medtronic, Edwards Lifesciences, Philips Healthcare, and most recently as CEO of On Target Laboratories. His experience spans businesses, securing FDA approvals, driving strategic M&A, and building global commercial franchises.
Warwick Freeman Chief Technology Office
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
D & Dj Burton Holdings Pty Ltd 96,002,819 49.94%
HSBC Custody Nominees (Australia) Limited 11,569,649 6.02%
B & R James Investments Pty Limited 5,000,000 2.60%
Beijing Bestmed Tech Ltd 4,901,961 2.55%
Medigas Italia S R L 4,333,333 2.25%
Mr David Francis Lawson & Ms Michelle Gabrielle Callinan 2,464,482 1.28%
Electro Molecular Pty Ltd 2,220,072 1.15%
Valui Pty Ltd 1,920,987 1.00%
BNP Paribas Noms (Nz) Ltd 1,606,224 0.84%
Ms Karin Jones 1,489,492 0.77%
Mr Mark David Holder 1,230,000 0.64%
Knowler Property Pty Ltd 1,198,000 0.62%
Jarvsofaks Pty Ltd 1,168,373 0.61%
Mr Bernard Frederick Knowler & Mrs Robynne Lynette Knowler 1,120,000 0.58%
Avianto Pty Ltd 1,079,975 0.56%
Mr Nigel Strong 1,008,786 0.52%
Mr David Francis Lawson 1,006,242 0.52%
P Morgan Nominees Australia Pty Limited 913,989 0.48%
Bfa Super Pty Ltd 778,188 0.40%
Cowan Grant Pty Ltd 768,000 0.40%

Profile

since

Note